GET DAILY SIGNALSAemetis (AMTX) Stock Falls -13% Over 30 Days as Post-Earnings Rally Fades
Key Takeaways
- Aemetis shares declined roughly 13% over the past 30 days, moving from about $1.56 to about $1.36 per share.
- The drop extended a longer slide: over the last quarter, the stock is down roughly 22% from the $1.75 area and a mid-August peak near $2.07.
- A strong third-quarter report released in early November triggered a brief rally that faded quickly, reflecting persistent concerns about liquidity and financing.
- Third-quarter 2026 results were solid — revenue up 49% to $88.2 million and net income of $5.2 million — but cash stood at just $3.4 million at quarter-end.
- Improved federal 45Z tax-credit economics and scaling dairy renewable natural gas output remain the core fundamental positives.
- For deeper analysis, explore the company's Price Targets, Earnings, and Forecast pages.
Aemetis (AMTX) Business Overview and Market Position
Aemetis, Inc. is a diversified renewable natural gas and biofuels company headquartered in Cupertino, California. Founded in 2006, the company operates a California dairy biogas digester network that converts dairy waste gas into renewable natural gas (RNG), along with a 65-million-gallon-per-year ethanol plant in Keyes, California, and an 80-million-gallon-per-year biodiesel facility on the East Coast of India operated through its Universal Biofuels subsidiary.
The company monetizes production through multiple revenue streams, including fuel sales, federal D3 renewable identification numbers (RINs), California Low Carbon Fuel Standard (LCFS) credits, and Section 45Z clean fuel production tax credits. Aemetis is also developing a sustainable aviation fuel plant and a CO2 sequestration project in California. Investors follow the stock for its exposure to low-carbon fuel policy tailwinds and its push toward positive cash flow as its RNG platform scales. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Aemetis (AMTX) Stock Price Performance: Last 30 Days vs. Quarter
Over the last 30 days, AMTX declined roughly 13%, from a closing price near $1.56 to approximately $1.36. The move was not a straight line: shares spiked sharply in early November after third-quarter results were released, jumping from about $1.25 to $1.73 in a single session on unusually heavy volume before retracing in the following days.
The quarterly picture is weaker. Measured over the last three months, the stock is down roughly 22% from the $1.75 area in mid-August. After reaching a multi-week high near $2.07 in late August, the shares trended steadily lower through September and October, with the post-earnings bounce in November proving short-lived.
What Drove AMTX Stock Price in the Last 30 Days
The most significant near-term catalyst was the company's third-quarter 2026 earnings report, released on November 5. Aemetis reported revenue of $88.2 million, up 49% year over year, and posted net income of $5.2 million, or $0.07 per basic share, versus a net loss of $23.7 million a year earlier. Adjusted EBITDA reached $24.8 million. Section 45Z tax-credit revenue totaled $24.7 million, including an $11 million cumulative true-up tied to a September update to the federal 45ZCF-GREET model that materially raised dairy RNG credit values.
Despite the headline improvement, the initial rally faded. The quarter ended with just $3.4 million in cash after $20.2 million of capital investment, and management indicated that most of the mechanical vapor recompression (MVR) project's financial benefit is now expected in the second half of 2027. Those liquidity and timing considerations, combined with profit-taking after the sharp earnings-day spike, weighed on the share price in subsequent sessions. From what I see, the post-earnings pullback highlights how quickly sentiment can shift when balance-sheet questions linger.
What Drove AMTX Stock Performance Over the Last Quarter
The broader three-month downtrend reflects a tension between improving operating results and persistent balance-sheet concerns. Second-quarter results reported in August showed revenue growth of 20% to $62.7 million and a return to operating profitability, but the stock had already begun to retreat from its late-August peak.
Investors have focused on the company's capital intensity, tight cash position, and reliance on tax-credit sales for liquidity, as well as the extended funding runway before the MVR project and continued RNG digester buildout fully contribute to cash flow. The possibility of additional financing, including a planned minority initial public offering of the India subsidiary, has also been a recurring point of focus as the market weighs dilution risk against the company's improving fundamentals. I’m watching this closely as the financing timeline unfolds.
AMTX Stock Forecast Drivers: What Investors Should Watch Next
Several factors will likely shape AMTX's trajectory in the quarters ahead. The completion of the MVR project — management has targeted construction completion around March 2027 — and the associated $32 million in projected annual cash-flow benefit are key milestones, along with the third corn-oil separation unit scheduled to begin operating in December. Additional Low Carbon Fuel Standard pathway approvals from the California Air Resources Board could further lift credit generation per unit of RNG.
Investors will also monitor 45Z credit monetization and the timing of cash receipts, ongoing financing plans for the Keyes plant and RNG buildout, progress toward a potential Universal Biofuels IPO, and ethanol and corn input costs. India biodiesel tender deliveries and any approval to export to Europe represent further demand levers. As with all renewable fuel producers, policy risk around federal and state credit programs remains an important variable.
Exploring Tickeron AI Tools in My Research
In my analysis of stocks like this, I often turn to Tickeron’s Trending AI Robots to review automated strategies that align with current market conditions. This page highlights top-performing bots across various approaches and timeframes, offering a data-driven way to complement fundamental research without replacing it. Results vary with market environments, so it serves as one more lens for evaluating potential opportunities systematically.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Momentum Indicator for AMTX turns positive, indicating new upward trend
AMTX saw its Momentum Indicator move above the 0 level on November 05, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 84 similar instances where the indicator turned positive. In 73 of the 84 cases, the stock moved higher in the following days. The odds of a move higher are at 87%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where AMTX's RSI Indicator exited the oversold zone, 40 of 48 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 83%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 57 of 69 cases where AMTX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 83%.
The Moving Average Convergence Divergence (MACD) for AMTX just turned positive on November 05, 2026. Looking at past instances where AMTX's MACD turned positive, the stock continued to rise in 32 of 38 cases over the following month. The odds of a continued upward trend are 84%.
Following a +50.43% 3-day Advance, the price is estimated to grow further. Considering data from situations where AMTX advanced for three days, in 187 of 232 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
Bearish Trend Analysis
AMTX moved below its 50-day moving average on November 10, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AMTX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.
AMTX broke above its upper Bollinger Band on November 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for AMTX entered a downward trend on November 04, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 59 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 71 (best 1 - 100 worst), indicating slightly worse than average price growth. AMTX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 87 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 94 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-0.363) is normal, around the industry mean (2.284). P/E Ratio (-1.884) is within average values for comparable stocks, (-17.137). AMTX's Projected Growth (PEG Ratio) (19.780) is very high in comparison to the industry average of (1.548). Dividend Yield (0.000) settles around the average of (0.039) among similar stocks. P/S Ratio (0.555) is also within normal values, averaging (48.960).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AMTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a producer of renewable chemicals and fuels using patented microbes and processes
Industry ChemicalsSpecialty
Advertisement